Sale!

Research Paper on Clinical data analysis and trial design issues with large COPD trials

Original price was: ₹21,240.00.Current price is: ₹10,620.00. inc. GST

Research Paper on Clinical data analysis and trial design issues with large COPD trials

1 in stock

Description

Title: Clinical data analysis and trial design issues with large COPD trials

Abstract: We will now go over some of the key findings from the TORCH and UPLIFT randomised controlled trials that have been conducted to determine the efficacy of COPD treatments. The study question must, first and foremost, be able to be answered by the study design. The TORCH study’s question was intended to be compared to “usual care,” but the placebo group was not “usual care.” Second, the intent-to-treat principle, which is essential to prevent bias in randomised trials, was followed for the first time in the TORCH and UPLIFT trials. The results regarding the decline in lung function are, however, subject to bias from regression to the mean because this principle was not followed for the lung function outcome but was for the mortality outcome. Last but not least, a re-analysis of the TORCH study (conducted to fully exploit the data as a 2 2 factorial trial) reveals that a mortality benefit is entirely explained by the effect of the long-acting b-agonist salmeterol, with no effect attributable to the inhaled corticosteroid fluticasone component of the combination therapy. Together, these findings imply that long-acting bronchodilators, such as beta-agonists and anticholinergics like tiotropium, are associated with lower COPD patient mortality but not inhaled corticosteroids. Mega trials like TORCH and UPLIFT are desperately needed because COPD is one of the leading causes of morbidity and mortality in the world, but they must adhere to the highest standards of scientific rigor in their planning and analysis.

Keywords: drug effectiveness, methods, chronic obstructive pulmonary disease, inhaled corticosteroids, anticholinergics, long-acting b-agonist

Paper Quality: SCOPUS / Web of Science Level Research Paper

Subject: Advances in Respiratory Medicine

Writer Experience: 20+ Years

Plagiarism Report: Turnitin Plagiarism Report will be less than 10%

Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.

What will I get after the purchase?

A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.

In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.